Seabridge Gold (SA) Announces $100M At-The-Market Offering

Seabridge Gold Inc. (NYSE: SA) announces that it has entered into a Controlled Equity Offering^SM Sales Agreement dated January 6, 2023 (the "Sales Agreement") with Cantor Fitzgerald & Co. (the "Lead Agent") and B. Riley Securities, Inc. (collectively with the Lead Agent, the "Agents"). Pursuant to the Sales Agreement, the Company will be entitled, at its discretion and from time-to-time during the term of the Sales Agreement, to sell, through the Lead Agent, such number of common shares of the Company (the "Common Shares") that would result in aggregate gross proceeds to the Company of up to US$100 million (the "Offering" or "ATM Facility"). Sales of the Common Shares, if any, will be made in "at the market distributions", as defined in National Instrument 44-102 - Shelf Distributions, directly on the New York Stock Exchange ("NYSE") or on any other existing trading market in the United States. No offers or sales of Common Shares will be made in Canada through the facilities of the Toronto Stock Exchange or other trading markets.

The program can be in effect until Seabridge's current US$750 million Shelf Registration Statement expires in January 2025. Net proceeds from the ATM Facility, if any, will be used to advance non-flow through eligible exploration and advancement of the Company's projects, potential future acquisitions, and for working capital and general corporate purposes.

Seabridge Chairman and CEO Rudi Fronk noted that the Company has had a similar ATM facility in place for many years. "This agreement replaces a previous agreement which has expired. We have found that our ATM programs in the past have enabled us to raise funds when needed at lower costs and with greater flexibility than more traditional financings. Any share issuance under the ATM is fully disclosed in our financial statements."

The Offering will be made by way of a prospectus supplement dated January 6, 2023 (the "Prospectus Supplement") to the Company's existing Canadian short form base shelf prospectus and U.S. registration statement on Form F-10, as amended (File No. 333-268485), dated December 23, 2022 and December 27, 2022, respectively (collectively the "Offering Documents"). The Prospectus Supplement will be filed with Securities Commissions in Canada and the U.S. Securities and Exchange Commission (the "SEC"). The Offering Documents will contain important detailed information about the securities being offered. Before you invest, you should read the Offering Documents and the documents incorporated therein for more complete information about the Company and the Offering. Copies of the Sales Agreement and the Offering Documents will be available for free by visiting the Company's profiles on the SEDAR website maintained by the Canadian Securities Administrators at www.sedar.com or the SEC's website at www.sec.gov, as applicable.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Breeze Acquisition Corp. II gets Nasdaq notice for late 10-Q filings
• Kairos Pharma announces 1-for-7 reverse stock split